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Abstract: Background: In pregnancy, excessive inflammation and break down of immunologic
tolerance can contribute to miscarriage. Endothelial cells (ECs) are able to orchestrate the
inflammatory processes by secreting pro-inflammatory mediators and bactericidal factors by
modulating leakiness and leukocyte trafficking, via the expression of adhesion molecules and
chemokines. The aim of this study was to analyse the differences in the phenotype between
microvascular ECs isolated from decidua (DECs) and ECs isolated from human skin (ADMECs).
Methods: DECs and ADMECs were characterized for their basal expression of angiogenic factors
and adhesion molecules. A range of immunological responses was evaluated, such as vessel leakage,
reactive oxygen species (ROS) production in response to TNF-α stimulation, adhesion molecules
expression and leukocyte migration in response to TNF-α and IFN-γ stimulation. Results: DECs
produced higher levels of HGF, VEGF-A and IGFBP3 compared to ADMECs. DECs expressed
adhesion molecules, ICAM-2 and ICAM-3, and a mild response to TNF-α was observed. Finally,
DECs produced high levels of CXCL9/MIG and CXCL10/IP-10 in response to IFN-γ and selectively
recruited Treg lymphocytes. Conclusion: DEC phenotype differs considerably from that of ADMECs,
suggesting that DECs may play an active role in the control of immune response and angiogenesis at
the foetal-maternal interface.
Keywords: endothelium; decidua; skin; angiogenesis; inflammation
1. Introduction
Endothelial cells (ECs) form a continuous barrier between blood and tissues and act as a gateway
to the traffic of molecules and cells across the vessel wall, playing an active role in homeostasis,
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inflammation and immunity [1]. They also play an important role in the onset and maintenance of
inflammation, being both target as well as source of cytokines, chemokines and growth factors [1].
ECs, although apparently similar to each other in function and morphology, represent a heterogeneous
population of cells in terms of inflammatory mediators secretion, adhesion molecules modulation,
leakiness and pro-coagulant activity [2]. The pathophysiological functions of ECs, which mainly relates
to angiogenesis and inflammation, take place at the level of the microvascular bed, which constitutes
the bulk of the overall endothelial surface [3]. The microenvironment as well as the epigenetics are
involved in determining ECs heterogeneity, resulting in tissue-specific properties [4]. Skin is the
primary interface between the body and the environment; skin injury or infections promptly result in
the activation of an efficient inflammatory response. Dermal microvascular ECs are active regulators of
the inflammatory process [5]. They contribute to the secretion of inflammatory mediators, bactericidal
molecules, increasing leakiness and pro-coagulant activity, modulation of adhesion and transmigration
of leukocytes through the expression of adhesion molecules and chemokines [6].
Decidua, the maternal part of human placenta, is derived from uterine endometrium through an
inflammatory process that leads to the transformation of endometrial stromal cells [7]. Consequently,
decidualization contributes to the activation of the local immune cells, such as Natural Killers (NK),
macrophages and T lymphocytes. These immune cells play a dual role in the decidual environment,
establishing immune tolerance and a mild inflammatory milieu, both being important for implantation
and pregnancy outcome [8]. During the early stages of pregnancy, a state of mild systemic inflammation
at the foetal-maternal interface is revealed by the presence of an activated vascular endothelium,
leukocytosis and increased activation of immune cells such as monocytes. Increased plasma levels of
inflammatory cytokines and chemokines, such as IL-8, IL-18, IL-12 and TNF-α are also observed [9].
Moreover, several immune cells, mainly uterine NK cells and macrophages, and to a lesser extent,
dendritic cells and T cells, are diffusely embedded in the decidual microenvironment and contribute to
the control of the immune response [10].
Decidual endothelial cells (DECs) are influenced by this special immunological and inflammatory
environment established in the decidua and play a key role in controlling the traffic of leukocytes
across the vessel wall, which needs to be tightly regulated in order to guarantee the success of the
pregnancy. In addition, DECs are involved in angiogenesis, a necessary process for decidualization,
which in turn, is an essential step in the maturation of new blood vessels in mammalian pregnancy.
The aim of this study was to characterize the phenotype of DECs in terms of expression of
molecules contributing to angiogenesis and leukocyte recruitment, and to compare it with the
microvascular ECs phenotype from human skin, which is normally geared to mount aninflammatory
response. Adult Dermal Microvascular ECs (ADMECs) were chosen as a cellular model
representingmicrovascular ECs that are physiologically involved in inflammatory responses. Although
similar to the commonly used HUVEC, ADMECs are more responsive to inflammatory stimuli [11]
and express different levels of endothelial markers [12].
2. Results
2.1. Decidual Endothelial Cells Express a Different Profile of Angiogenic Factors and Adhesion Molecules
Compared to Endothelial Cell Isolated from Dermal Skin
Since DECs are the only ECs, which under physiological conditions, are able to synthesize
the complement component C1q [13], an extensive characterization of DEC phenotype was carried
out. Initially, a gene expression profiling using isolated primary human ADMECs and DECs was
performed. The isolated cells were found to be 100% positive for the pan-endothelial cell markers
VE-cadherin (CD144), von Willebrand Factor (vWF), and mesenchymal marker, vimentin, as assessed
by immunostaining (Figure 1). A comparison of the gene expression profiles between DECs and
ADMECs revealed 1909 transcripts that were differentially expressed (t-test p-value <0.01 and fold
change ≥1), 1652 of which were up-regulated and 255 down-regulated in the DEC population
(Supplementary Figure S1).
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Figure 1. Phenotypic characterization of DECs and ADMECs. (A) Immunofluorescence analysis of 
vWF, VE-cadherin and vimentin on isolated and cultured DECs and ADMECs. Original 
magnification: 200×. (B) RT-qPCR of VEGF-A, HGF, IGFBP3, ICAM-2 and ICAM-3 genes 
differentially expressed by DECs and ADMECs. The data represent the mean ± SD of triplicate 
samples from five separate experiments, * p <0.05, ** p <0.01, *** p <0.005. (C) Evaluation of the 
production of VEGF-A, HGF and IGFBP3 proteins in the supernatants of a confluent monolayer of 
DECs and ADMECs after 4h of culture using a commercial ELISA kit. The data represent the mean ± 
SD of triplicate samples from five separate experiments. * p <0.05, ** p <0.01, *** p <0.005. (D) 
Cytofluorimetric analysis for the expression of ICAM-2 and ICAM-3 in basal condition of freshly 
isolated DECs and ADMECs. The ECs were incubated with PE-conjugated mouse anti-human ICAM-
2 and ICAM-3 mAb. PE-conjugated isotype-matched IgG2a or IgG1 were used as negative control, 
respectively. Data are represented as mean ± SD of the Mean Fluorescence Intensity (MFI) of five 
separate experiments. 
Analysis of the gene expression profile (GEP) data revealed, besides other genes, interesting 
differences in the expression of genes involved in angiogenesis and leukocyte recruitment. In 
particular, we observed a 2.7 fold up-regulation of VEGF-A; a 2.1 fold increase in the expression of 
HGF, and even more pronounced up-regulation (11.6 fold) of IGFBP3 (Supplementary Figure S1). 
The expressions of VEGF-A, HGF and IGFBP3 transcripts were validated by RT-qPCR using 
microarray samples as well as five additional EC populations each obtained from other subjects 
(Figure 1B). The results presented in Figure 1B confirmed the difference in gene expression levels of 
these growth factors. The production of VEGF-A, HGF and IGFBP3 was also analysed at protein level 
by ELISA in the supernatants of five different populations of DECs and ADMECs (Figure 1C). The 
results shown in Figure 1C indicated that DECs produced higher amount of VEGF-A, IGFBP3 and 
HGF as compared to ADMECs. The microarray and RT-qPCR analysis also revealed a higher 
fl
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experiments, * p < 0.05, ** p < 0.01, *** p < 0.005. (C) Evaluation of the production of VEGF-A, HGF
and IGFBP3 proteins in the supernatants of a conflue t monolayer of DECs and ADMECs after 4 h f
culture using a commercial ELISA kit. The data represent the mean ± SD of triplicate samples from
five separate experiments. * p < 0.05, ** p < 0.01, *** p < 0.005. (D) Cytofluorimetric analysis for the
expression of ICAM-2 and ICAM-3 in basal condition of freshly isolated DECs and ADMECs. The ECs
were incubated with PE-conjugated mouse anti-human ICAM-2 and ICAM-3 mAb. PE-conjugated
isotype-matched IgG2a or IgG1 were used as negative control, respectively. Data are represented as
mean ± SD of the Mean Fluorescence Intensity (MFI) of five separate experiments.
Analysis of the gene expression profile (GEP) data revealed, besides other genes, interesting
differences in the expression of genes involved in angiogenesis and leukocyte recruitment. In particular,
we observed a 2.7 fold up-regulation of VEGF-A; a 2.1 fold increase in the expression of HGF, and even
more pronounced up-regulation (11.6 fold) of IGFBP3 (Supplementary Figure S1). The expressions
of VEGF-A, HGF and IGFBP3 transcripts were validated by RT-qPCR using microarray samples as
well as five additional EC populations each obtained from other subjects (Figure 1B). The results
presented in Figure 1B confirmed the difference in gene expression levels of these growth factors.
The production of VEGF-A, HGF and IGFBP3 was also analysed at protein level by ELISA in the
supernatants of five different populations of DECs and ADMECs (Figure 1C). The results shown in
Figure 1C indicated that DECs produced higher amount of VEGF-A, IGFBP3 and HGF as compared to
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ADMECs. The microarray and RT-qPCR analysis also revealed a higher expression of the constitutive
adhesion molecules, ICAM-2 and ICAM-3, by DECs. These data were confirmed at the protein level by
cytofluorimetric analyses (Figure 1D).
2.2. DECs Respond Feebly to Vasoactive Stimuli Leading to Vascular Leakage Compared to ADMECs
To investigate the unique characteristics of DECs in terms of inflammatory response, an
endothelial permeability assay was carried out. ECs were grown to confluence onto a transwell (TW)
insert. To measure the vascular permeability, ECs were treated with Platelet-Activating Factor (PAF),
Histamine (HIS) or Bradykinin (BK). To determine the increase in ECs permeability, FITC-conjugated
BSA was added to the upper chamber. The passage of FITC-BSA to the lower chamber was evaluated
after 5, 15 and 30 min and the results were expressed as % of BSA leakage. As shown in Figure 2,
ADMECs promptly responded to all three vasoactive stimuli. On the contrary, DECs were not
responsive to vasoactive stimuli even after 30 min of incubation.
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Figure 2. Permeabilizing activity of endothelial cells to classical vasoactive stimuli. The permeabilizing
activity was evaluated kinetically, after 5 (A), 15 (B) and 30 min (C) adding PAF (D), HIS (E) or BK (F),
to the upper chamber of the TW, measuring the amount of FITC-labeled BSA that leaked through a
monolayer of endothelial cells into the lower chamber. The data represent the mean ± SD of duplicate
samples from four separate experiments * p < 0.05; ** p<0.01; *** p < 0.005.
2.3. DECs Produce Lower Levels of Oxygen-Derived Reactive Molecules than ADMECs in Response to TNF-α
and Histamine Challenge
We evaluated the capability of DECs and ADMECs to produce H2O2, an oxygen-derived reactive
molecule endowed with bactericidal properties. Both ECs, cultured in 96 well plates, were incubated
with Ampliflu Red reagent, a molecule that produces a fluorescent signal following its reaction with
H2O2. As expected, ADMECs were able to produce high levels of H2O2 in response to both TNF-α and
histamine stimulation. On the contrary, DECs maintained a lower level of H2O2 production following
stimulation with TNF-α and histamine (Figure 3).
2.4. DECs, Compared to ADMECs, Are Weak Responders to TNF-α Stimulation with Respect to Chemokine
Secretion, Adhesion Molecule Expression and Leukocyte Recruitment
Another important aspect of ECs function is their key role in controlling leukocyte trafficking
across the vessel wall. It is well known that ECs, including ADMECs, promptly respond to TNF-α
by enhancing adhesion molecule expression and cytokine secretion [14,15]. This results in leukocyte
adhesion and transmigration into tissue spaces. We, therefore, analysed the expression of selected
chemokines (IL-8, MCP-1, MIP-1α and RANTES) in resting as well as TNF-α stimulated ECs. ECs
were inc bated vernight with TNF-α and supernatants were collected. ECs were then lysed and
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the total mRNA was extracted. The gene expression analysis (data not shown) and the chemokine
quantification in the culture supernatant revealed a statistically significant weaker responsiveness
of DECs to TNF-α stimulation (Figure 4A–D); only IL-8 production was comparable between DECs
and ADMECs.
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Figure 3. Production f i t ll l t li l cells. production by endothelial cells
exposed to T F- ( ) or IS ( ). Follo i g re-treat ent ith T F-α (100 ng/ ) or ista ine (HIS;
0.1 µ ), E s ere stained ith pliflu Red for the evaluation of H2O2 production after 30, 60 120,
180 and 240 min. (C) Histograms represent the production of intracellular ROS by endothelial cells
stimulated with TNF-α or HIS after 120 min. The data represent the mean ± SD of triplicate samples
from five separate experiments; * p < 0.05.
The expression of ICAM-1, VCAM-1 and E-Selectin, which are inducible adhesion molecules
involved in leukocyte recruitment, can be modulated by TNF-α. Monolayers of DECs and ADMECs
were stimulated with TNF-α for 4 h (or 18 h for VCAM-1) and the expression of these adhesion
molecules was evaluated by ELISA on the whole cells. The results are shown in Figure 4E and
are expressed as fold of increase compared to resting condition. ADMECs, as expected, showed a
significant up-regulation of ICAM-1, VCAM-1 and E-Selectin expression on their cell surface after
stimulation with TNF-α, whereas DECs showed weaker surface expression of adhesion molecules.
In order to ascertain if feeble surface expression of adhesion molecules by DECs, following
TNF-α challenge, coincided with a functional deficit in the leucocyte recruitment, we performed a
trans-endothelial migration assay using Lympho-Monocytes (LM) isolated from peripheral blood. ECs
were grown to confluence in the TW system and stimulated with TNF-α. Subsequently, peripheral
blood LM were added to the upper chamber of the TW, allowed to migrate for 30 min, and then
counted. As showed in Figure 4F, TNF-α stimulated DECs brought about a considerably reduced LM
recruitment compared to ADMECs.
2.5. IFN-γ-stimulated DECs Are Potent Recruiters of Natural Killer and Regulatory T Cells
Chemokines such as CXCL9/MIG and CXCL10/IP-10 are important in controlling the recruitment
and/or retention of NK cells in human decidua [16]. Since CXCL9/MIG and CXCL10/IP-10 are
inducible by IFN-γ, we asked whether the production of these two chemokines by DECs could be
modulated in response to IFN-γ. As shown in Figure 5, IFN-γ-stimulated DECs, but not ADMECs,
secreted high amounts of both chemokines.
We performed a migration assay with lympho-monocytes (LM) using the supernatant of cells
stimulated with IFN-γ (as chemoattractant) in order to establish the functional consequences of
these chemokines produced by DECs (Supplementary Figure S2). In addition, we characterized the
DEC-recruited cells that migrated to the lower compartment of the Boyden Chamber during the
trans-endothelial migration assay. ECs were grown to confluence in the TW system and stimulated
overnight with IFN-γ. Peripheral blood LM were then added in the upper chamber and allowed
to migrate for 30 min. Migrated cells were stained for CD45+CD56+, CD3+CD4+, CD3+CD8+,
and CD3+FoxP3+ using appropriate monoclonal Abs. Interestingly, besides CD45+CD56+ NK cells
(Supplementary Figure S3), DECs also exhibited a considerably enhanced ability to recruit Treg cells
(CD3+FoxP3+), as compared to ADMEC (Figure 5C,D).
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3. Discussion
In this paper, we report, for the first ti e, a detailed characterization of the phenotype of DECs
that can differentially impact upon angiogenesis and leukocyte recruitment. As a point of reference,
we used microvascular ECs derived from human skin which are normally robust participants during
pro-inflammatory response.
Microvascular endothelial cells are active participants in and regulators of the inflammatory
processes. They contribute to the process by (i) secreting inflammatory mediators and bactericidal
molecules; (ii) increasing leakiness and pro-coagulant activity; (iii) modulating adhesion and migration
of leukocytes through the expression of adhesion molecules and chemokines; and (iv) promoting
pro-inflammatory cytokine expression [6].
In this study, we compared a range of immunological features of DECs and ADMECs, two types of
microvascular ECs derived from very distinct anatomical sites. ADMECs are derived from a vascular
location actively involved in the inflammatory process [5], whereas DECs are derived from decidua,
where uncontrolled or heightened infla matory milieu is unwarranted and can potentially lead to
miscarriage or pregnancy related complications [17].
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There are few studies concerning the characterization of DECs. Burrows and colleagues in 1994
described the basal level expression of adhesion molecules by immunohistochemistry, demonstrating
that ICAM-1 is expressed by all vascular endothelium throughout the decidua [18]. However, it
principally focused on differential marker expression ex vivo [18,19]. Alternatively, cells isolated from
non-pregnant uterus were also employed to describe DEC properties [20–22].
We have previously shown that DECs are the only ECs able to express the complement
protein C1q under basal physiologic conditions [13]. C1q, besides its well-known function as
the recognition subcomponent of the complement classical pathway, is involved in trophoblast
endovascular invasion [23]. The current study highlights a range of additional features of DECs.
Most crucially, DECs produce a high amount of several important regulators of angiogenesis such
as VEGF-A, HGF and IGFBP3. DECs also express high levels of the adhesion molecule ICAM-2 on
their cell surface under basal conditions, and are the exclusive endothelial cell population that express
ICAM-3, characteristics that have only been associated with the High Endothelial Venules (HEVs) so
far [24].
DECs are unable to enhance inflammasome components in response to LPS stimulation [25].
More recently, comparing their immunological phenotype to that of other ECs such as HUVEC and
ADMEC, DECs were found to be hypo-responsive to LPS stimulation in terms of IL-6, CXCL8/IL-8 and
CCL2/MCP-1 production since they expressed low levels of TLR4 and manifested strong constitutive
activation of the non-canonical NF-κB pathway and low responsiveness of the canonical pathway to
LPS [26].
ECs play a pivotal role in regulating the selective passage of molecules that need to be recruited
at the extravascular sites and participate in the control of fluid movement between luminal and
ab-luminal sides of the vessels. Vascular permeability increase takes place mainly in post-capillary
venules where the ECs are able to respond to different stimuli such as histamine, thrombin and
bradykinin [27,28]. Indeed, ADMEC showed a prompt permeabilizing response to all the stimuli
used (PAF, HIS, BK). DECs, however, were unable to show an increased vascular permeability. This
unusual behaviour probably reflects some differences in receptor expression or intracellular signals
triggered by receptor-agonist interaction. For BK, there are different types of receptors expressed on
the cell surface and it has been demonstrated that only B2, and not B1, receptors are expressed at
decidual level [29]. Moreover, as compared to other situations that involve specific modulation of
vascular leakage, it has been shown that B1 receptor could also be important in the dermal vascular
permeability [30], indicating a differential functional response between DEC and ADMEC. Besides
vascular permeability, DECs are less efficient in the production of bactericidal molecules both in basal
condition and in response to TNF-α and histamine stimulation.
Interestingly, while analysing DECs responses, an absent or mild modulation of the adhesion
molecules, ICAM-1, VCAM-1 and E-selectin respectively, was observed when compared to ADMEC.
Low or undetectable amounts of the chemokines, CCL2/MCP-1, CCL3/MIP-1α and CCL5/RANTES,
after stimulation with the pro-inflammatory cytokine TNF-α, were found in DECs. This is in contrast
to the typical effect of TNF-α that normally induces endothelial activation, which is accompanied by
an increase in adhesion molecule expression and cytokine production [31]. These data indicate that
DECs are hyporesponsive to pro-inflammatory stimuli in comparison with other endothelial cells and
could actively participate in the control of leukocyte infiltration/trafficking in decidua.
DECs appear to be unique in their ability to respond to IFN-γ, another pro-inflammatory cytokine,
mainly produced in decidua by decidual NK cells [32]. DECs, but not ADMECs, produced a large
amount of CXCL9/MIG and CXCL10/IP-10. DECs were shown to be able to express the mRNA for
CXCL10/IP-10 also after progesterone treatment [33] and in response to trophoblast conditioned
medium exposure [34]. The production of CXCL10/IP-10 was shown to be important for the
recruitment of uterine NK cells in maternal decidua inducing the migration of peripheral blood
NK cells derived from first trimester pregnant women, across DECs and decidual stromal cells [33]. In
this paper, we also demonstrated that DECs stimulated with IFN-γ recruited a higher percentage of
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CD3+FoxP3+ cells in comparison to ADMECs, although other markers (CD25, CD127) will be useful
for a further characterization of Treg. Whether dysfunctional decidual endothelium can tip the balance
away from the preponderance of Treg needs to be ascertained since maternal Tregs have been linked
with a number of pregnancy-related complications. It is clear from this study that DECs are likely
to be one of the lynchpins for proper recruitment and functioning of maternal NK cells, decidual
macrophages and maternal Treg, each cell type being known to play a hierarchical role within the three
trimesters of pregnancy.
4. Materials and Methods
4.1. Cell Isolation and Culture
Decidual first trimester biopsy specimens were obtained from healthy women (n = 8) undergoing
voluntary termination of pregnancy at 8–12 weeks of gestation. Skin samples were obtained from
women (n = 6) of fertile age undergoing reductive plastic surgery. The study was approved by the
institutional review board of the Institute for Maternal and Child Health (IRCCS “Burlo Garofolo”,
Trieste, Italy. Approval 13 December 2009). I Informed consent was obtained from all women providing
the tissue specimens. DECs and ADMECs were isolated and characterized as previously described [13].
Each population corresponded to a single woman. Both ECs were seeded in a 12.5 cm2 flask precoated
with 2 µg/cm2 fibronectin (Roche, Milan, Italy) and maintained in endothelial serum free basal
medium (Life Technologies, Monza, Italy), supplemented with 20 ng/mL basic Fibroblast Growth
Factor, 10 ng/mL Epidermal Growth Factor (Life Technologies), 10% v/v foetal calf serum (FCS) (Life
Technologies), and 10% v/v human serum.
DECs were positively selected using Dynabeads M-450 (Life Technologies) coated with Ulex
europaeus 1 lectin (Sigma–Aldrich, Milan, Italy), whereas ADMECs were further purified from a
subconfluent mixed cell population using CD31-conjugated magnetic beads from Dynabeads (Life
Technologies). When the cells were seeded for the experiments, the medium used was the same as
described above but without human serum.
4.2. Immunofluorescence
ECs were plated on 8-chamber culture slides (BD Biosciences Discovery Labware, Milan, Italy)
coated with 2 µg/cm2 fibronectin (Roche, Milan, Italy). When cells grew to confluence, they were
fixed and permeabilized with FIX & PERM (Società Italiana Chimici, Rome, Italy). Then cells
were incubated with primary monoclonal antibody (mAb) (clone 9) mouse anti-human vimentin
(Sigma-Aldrich), (cloneF8/86) mouse anti-human vWF (Dako-Cytomation, Milan, Italy), or mouse
anti-human VE-Cadherin (kindly provided by Prof. Dejana from Institute of Molecular Oncology,
Milan, Italy) (5 µg/mL) for 1 h at room temperature (RT) followed by fluorescein isothiocyanate
(FITC)-conjugated goat anti-mouse IgG for 1 h at RT. Images were acquired with Leica DM3000
microscope (Leica, Wetzlar, Germany) and collated using a Leica DFC320 digital camera (Leica).
4.3. RNA Isolation, cDNA Synthesis and Quantitative Real-Time Polymerase-Chain Reaction (RT-qPCR)
RNA was extracted from cells with euroGOLDtrifast (Euroclone, Milan, Italy) according to the
supplier’s instructions and reverse transcripted as previously described [13]. qPCR was carried out on
a Rotor-Gene 6000 (Corbett, Explera, Ancona, Italy) using iQ SYBR Green Supermix (Bio-Rad, Milan,
Italy). Supplementary Table S1 shows the primers used for RT-qPCR. The melting curve was recorded
between 55 ◦C and 99 ◦C with a hold every 2s. The relative amount of gene expression in each sample
was determined by the Comparative Quantification (CQ) method supplied as part of the Rotor Gene
1.7 software (Corbett Research) [35]. The relative amount of each gene was normalized with 18S and
expressed as arbitrary units (AU) considering 1 AU obtained from decidual tissue used as a calibrator.
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4.4. Microarray
Total RNAs from ECs were validated for integrity and purity using the Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). Single-color hybridization microarray experiments for
gene expression profile (GEP) were performed with 100 ng total RNA/sample labeled with Cyanine
(Cy)-3 dye using the Low Input Quick Amp Labeling Kit (Agilent Technologies). Cy3-labeled RNA was
hybridized to the Whole Human Genome (4 × 44 K) oligo microarray platform (Agilent Technologies).
Microarray slides were analysed with an Agilent Microarray Scanner (Agilent Technologies). The
hybridization signal values for the multiple probes for each gene were obtained with the use of Agilent
Feature Extraction Software 10.7.3 (Agilent Technologies). Bioinformatics analyses were performed
using GeneSpring 11.5.1 (Agilent Technologies). GEP results were visualized by hierarchical clustering,
applying Ward’s method with Euclidean distance [36]. GEO number: GSE41946.
4.5. Growth Factors and Chemokines Detection
ECs were grown to confluence in 24 wells plate (BD Falcon) in serum-free medium and stimulated
for 24 h with IFN-γ (100 U/mL) or TNF-α (100 ng/mL) (Peprotech, Milan, Italy). The levels of VEGF-A,
HGF, IGFBP3 were measured by commercial ELISAs following the manufacturer’s instruction (VEGF
Human ELISA Kit, Invitrogen Milan Italy; Boster Immunoleader Tema Ricerca, Bologna Italy, for
detection of HGF; DRG Products Tema Ricerca, Bologna Italy for detection of IGFBP3). The quantitative
determination of IL-8, MCP-1, MIP-1α, RANTES, CXCL9/MIG and CXCL10/IP-10 was performed
by a bead-based multiplex immunoassay (Biorad) and a Bioplex 200 system (Biorad Laboratories,
Hercules, CA, USA), as previously described [37]. The cells were then lysed for the quantification of
the total protein content by Bradford assay [24].
4.6. Migration Assays
LM were isolated as previously described [24]. ECs (2 × 104) were seeded onto 20 µg/mL
fibronectin-coated polycarbonate insert of a 24-well TW system (6.5 mm diameter, 8-µm pores; Corning
Costar, Milan, Italy) and used 5 days after culture as previously described [33]. LM suspension (2 ×
105 cells/100 µL endothelial serum free basal medium with 0.1% w/v bovine serum albumin) was
added to the upper compartment of the TW in the presence or absence of ECs and allowed to migrate
through DECs for 1 h at 37 ◦C. Amounts of 10% FCS, IFN-γ, or conditioned medium (CM) of DECs
treated with IFN-γ were added to the lower chamber as a chemoattractant for LM. The number of cells
transmigrated was evaluated by Coulter Counter (Coulter Electronics, Luton, UK).
Migrated LM were fixed with FIX & PERM® cell fixation and permeabilization kit (Società Italiana
Chimici), according to the manufacturer’s instructions. A total number of 5 × 105 cells were incubated
on shaking at 800 rpm overnight at 4 ◦C with PE- or FITC-conjugated mouse monoclonal antibody
(mAb) specific to human CD3 (clone MEM-57), CD8 (clone MEM-31), CD45 (clone MEM-28), CD56
(clone MEM-188) (ImmunoTools GmbH) and IgG1 and IgG2a (ImmunoTools GmbH) isotype controls.
Cells were fixed with 1% v/v PFA (Sigma-Aldrich) and analysed for fluorescence with a FACSCalibur
flow cytometer (BD Falcon) using CellQuest software (version 5.1, Becton Dickinson European HQ,
Erembodegem-Aalst, Belgium).
4.7. Detection of Adhesion Molecules on ECs
ICAM-2 and ICAM-3 were examined via cytofluorimetric analysis [13]. ECs were incubated
for 1 h at 37 ◦C with the phycoerythrin (PE)-conjugated mAb ICAM-2 (clone CBR-IC2/2) or
with PE-conjugated mAb ICAM-3 (clone CBR-IC3/1) (Biolegend, Milan, Italy) and their relatives
PE-conjugated mouse IgG2a or IgG1 (ImmunoTools GmbH, Friesoythe, Germany) isotype controls.
Quantization of ICAM-1, VCAM-1 and E-Selectin was evaluated by an ELISA on the whole cells, in
ECs stimulated for 4 h (for ICAM-1 and E-Selectin) or 18 h (for VCAM-1) with TNF-α (100 ng/mL)
and then incubated with monoclonal primary antibodies (mAb 6.5B5 anti-ICAM-1, mAb clone 1.4C3
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anti-VCAM-1 Sigma-Aldrich or mAb clone 1.2B6 anti-E-selectin; 5 µg/mL) for 1 h at RT, as previously
described [38]. The cells were then lysed for the quantification of the total protein concentration via
Bradford assay [24].
4.8. Endothelial Leakage
Human endothelial cells (ECs; 2 × 104) were seeded onto polycarbonate inserts of a 24-well TW
system (6.5-mm diameter, 3-µm pores; Corning Costar, Milan, Italy) coated with 2 µg/cm2 of human
fibronectin and used after reaching the confluence. Each TW was checked for the formation of intact
monolayer on the insert by adding FITC-BSA (1 mg/mL) to the upper chamber and measuring the
amount of labelled BSA that passed down to the lower chamber by an Infinite200 (TECAN). The TWs
were used only when the intensity of fluorescence in the lower chamber was negligible; in this case,
the stimuli were added to the upper chamber together with FITC-BSA and the fluorescence evaluated
in the lower chamber at various time points.
4.9. Measurement of Total H2O2 Production
Hydrogen peroxide (H2O2) production was measured using Ampliflu Red (Sigma-Aldrich)
reagent. ECs were seeded on 96-well plate to reach 90% confluence. To assess total H2O2, the cell
culture medium was substituted with PBS + 2% w/v BSA + 0.7 mM MgCl2 and 0.7 mM CaCl2
containing 40 µM Ampliflu Red reagent, 1 µg/mL HRP, 5 µg/mL SOD and 100 µM NaN3 in a final
volume of 100 µL. After 5 min of preincubation with TNF-α (100 ng/mL) or Histamine 10−5 M,
the readings were taken at 576 nm with Infinite200 (TECAN). The cells were then lysed for the
quantification of the total protein concentration by Bradford assay [24].
4.10. Statistic Analysis
Data were analysed using Two-way ANOVA, Tukey–Kramer test, and unpaired two-tailed
Student’s t-test or one-way ANOVA with Bonferroni corrections. Results were represented as mean ±
SEM. Non-parametric data were assessed by Mann–Whitney U tests and the results were expressed as
median and interquartile range. p values < 0.05 were considered significant. All statistical analyses
were performed using Prism 6 software (GraphPad Software Inc., La Jolla, CA, USA).
5. Conclusions
DECs differ from ADMECs with respect to the production of several growth factors that play
important roles in the control of angiogenesis. DECs also differ from ADMECs in the expression
of adhesion molecules and the release of chemokines involved in local leukocyte recruitment, thus
contributing to the establishment of the special decidual microenvironment. Our results indicate that
DECs display a differential “arsenal” of adhesion molecules and cytokines in response to classical
pro-inflammatory stimuli compared to ADMECs and HUVEC: they express constitutively the adhesion
molecules ICAM-2 and ICAM-3, but fail to show increased expression of ICAM-1. These cells produce
higher levels of the chemokines CXCL9/MIG and CXCL10/IP-10 in response to IFN-γ compared to
other ECs, and promote selective migration of FoxP3 positive T cells. These findings are consistent
with the local changes that occur during pregnancy which are designed to control the inflammatory
response at the foetal-maternal interface. Thus, similar to T-cells, macrophages, dendritic cells and
neutrophils, there may be a paradigm shift in the endothelial cells towards an anti-inflammatory
phenotype EC2.
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ADMECs Adult Dermal Microvascular Endothelial cells
AU Arbitrary Units
BK Bradykinin
BSA Bovine Serum Albumin
C1q Complement component 1q
CCL Chemokine (C–C motif) Ligand




CXCL Chemokine (C–X–C motif) Ligand
DECs Decidual endothelial cells
ECs Endothelial cells
ELISA Enzyme-Linked ImmunoSorbent Assay
E-Selectin Endothelial–Selectin
FCS Foetal Calf Serum
FITC Fluorescein Isothiocyanate
FoxP3 Forkhead box P3
GEO Gene Expression Omnibus
GEP Gene Expression
HEVs High Endothelial Venules
HGF Hepatocyte Growth Factor
HIS Histamine
HRP Horseradish Peroxidase
HUVECs Human Umbilical Vein Endothelial Cells
ICAM Intercellular Adhesion Molecule
IFN-γ Interferon gamma
IGF-1 Insulin-like Growth Factor-1
IGFBP3 Insulin-like Growth Factor-Binding Protein 3
IgG Immunoglobulin G
IL Interleukin




MCP-1 Monocyte Chemoattractant Protein-1
MIG Monokine Induced by Gamma
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RANTES Regulated on Activation, Normal T cell Expressed and Secreted
ROS Reactive Oxygen Species
RT Room Temperature
RT-qPCR Quantitative real-time polymerase-chain reaction
SOD Superoxide Dismutase
TLR4 Toll-Like Receptor 4
TNF-α Tumor Necrosis Factor α
Treg Regulatory T
TW Transwell
VCAM-1 Vascular Cell Adhesion Protein-1
VE-cadherin Vascular endothelial cadherin
VEGF-A Vascular Endothelial Growth Factor A
vWF von Willebrand Factor
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